At close to €350 billion, the value of the European biopharmaceutical market is second only to the US.  But with different nations working on different rules and regulations, drug discovery and clinical development across borders aren’t always straightforward. This has bred a unique ecosystem of biopharma companies served by innovative solution providers on a local, continental and global level.

​

With excellent travel links via air and rail, it is easy to see why Amsterdam has become such a hub of innovation for life sciences and is the natural choice in which to host COG Europe 2024.

​

COG Europe brings together senior decision-makers across from all four corners of Europe to hear from thought leaders within industry, regulators, and academia alongside a group of the most trusted and innovative solution providers serving the European market for two days of leading multi-stream agenda content and networking engagement at a luxury Amsterdam hotel.

​

We're delighted to host COG Europe as the premier meeting place for the European clinical research community and look forward to welcoming you to Amsterdam in November.